文献速递头颈神经MR

头颈部肿瘤:酰胺质子转移MRI

Head and Neck Tumors: Amide Proton Transfer MRI.
PubMed 文献 · Radiology · 2018-06-12

本回顾性研究纳入117例头颈部肿瘤患者,评估酰胺质子转移(APT)成像在肿瘤定性中的价值。恶性肿瘤平均APT值显著高于脑组织、肌肉组织和良性肿瘤,但恶性组间无差异;APT联合ADC将鉴别良恶性的曲线下面积从0.87提高至0.96,整合判别指数为7.6%(P = .13)。

要点

  • 恶性肿瘤平均APT值2.40% ± 0.97,显著高于良性肿瘤1.32% ± 1.20(P < .001)。
  • APT联合ADC鉴别良恶性肿瘤的AUC从0.87升至0.96,整合判别指数7.6%(P = .13)。
  • APT均值无法区分鼻咽未分化癌、鳞状细胞癌和非霍奇金淋巴瘤(P = .45至P = .86)。

核心结论

  • 初步数据显示恶性肿瘤、正常组织和良性肿瘤的APT均值存在差异,但APT均值不能用于区分恶性肿瘤组间;APT成像可能为ADC鉴别良恶性肿瘤提供附加价值。

研究设计与样本

  • 回顾性研究,纳入117例头颈部肿瘤患者(鼻咽未分化癌70例、鳞状细胞癌26例、非霍奇金淋巴瘤8例、良性涎腺肿瘤13例),另在25例患者中检查正常组织;采用APT成像,以平均APT值和平均ADC为指标,用Student t检验和方差分析比较,用受试者工作特征分析和整合判别指数评估APT对ADC的附加价值。

关键影像表现/征象

  • 恶性肿瘤平均APT值为2.40% ± 0.97,高于脑组织1.13% ± 0.43、肌肉组织0.23% ± 0.73和良性肿瘤1.32% ± 1.20(P < .001)。
  • 恶性肿瘤平均ADC为(0.85 ± 0.17)× 10-3 mm2/sec,低于良性肿瘤(1.46 ± 0.47)× 10-3 mm2/sec(P = .001)。

诊断标准与关键数值

  • 恶性组间平均APT值无差异:鼻咽未分化癌2.37% ± 0.90、鳞状细胞癌2.41% ± 1.16、非霍奇金淋巴瘤2.65% ± 0.89(P = .45至P = .86)。
  • ADC单独鉴别良恶性肿瘤的AUC为0.87,APT联合ADC的AUC为0.96,整合判别指数为7.6%(P = .13)。

局限性

  • 原文结论称这些为初步数据(preliminary data)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To evaluate the utility of amide proton transfer (APT) imaging in the characterization of head and neck tumors. Materials and Methods This retrospective study of APT imaging included 117 patients with 70 nasopharyngeal undifferentiated carcinomas (NUCs), 26 squamous cell carcinomas (SCCs), eight non-Hodgkin lymphomas (NHLs), and 13 benign salivary gland tumors (BSGTs). Normal tissues were examined in 25 patients. The APT means of malignant tumors, normal tissues, and benign tumors were calculated and compared with the Student t test and analysis of variance. The added value of the mean APT to the mean apparent diffusion coefficient (ADC) for differentiating malignant and benign tumors was evaluated by using receiver operating characteristic analysis and integrated discrimination index. Results The mean APT of malignant tumors (2.40% ± 0.97 [standard deviation]) was significantly higher than that of brain tissue (1.13% ± 0.43), muscle tissue (0.23% ± 0.73), and benign tumors (1.32% ± 1.20) (P < .001). There were no differences between malignant groups (NUC, 2.37% ± 0.90; SCC, 2.41% ± 1.16; NHL, 2.65% ± 0.89; P = .45 to P = .86). The mean ADC of malignant tumors ([0.85 ± 0.17] × 10-3 mm2/sec) was significantly lower than that of benign tumors ([1.46 ± 0.47] × 10-3 mm2/sec) (P = .001). Adding APT to ADC increased the area under the curve from 0.87 to 0.96, with an integrated discrimination index of 7.6% (P = .13). Conclusion These preliminary data demonstrate differences in amide proton transfer (APT) mean of malignant tumors, normal tissues, and benign tumors, although APT mean could not be used to differentiate between malignant tumor groups. APT imaging has the potential to be of added value to apparent diffusion coefficient in differentiating malignant from benign tumors.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Law BKH, King AD, Ai QY, et al. Head and Neck Tumors: Amide Proton Transfer MRI. Radiology. 2018. PMID: 29893646. doi:10.1148/radiol.2018171528

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。